Correlation between the status of the miR-31 host gene locus and pathologic subjects.

*Significant in a one-way ANOVA analysis; BRE versus ADC, P<0.0001; BRE versus SQC, P<0.0001; BRE versus LCC, P = 0.0008; ADC/WEL versus ADC/POR, P = 0.0049; ADC/MOD versus ADC/POR, P = 0.0332; BAC versus SOL, P = 0.0013; PAP versus SOL, P = 0.0433; MUC versus SOL, P = 0.0007; ADC, adenocarcinoma; SQC, squamous cell carcinoma; LCC, large cell carcinoma; BRE, bronchial epithelia; WEL, well differentiated; MOD, moderately differentiated; POR, poorly differentiated carcinomas; BAC, bronchioloalveolar carcinoma; ACI, acinar adenocarcinoma; PAP, papillary adenocarcinoma; SOL, solid adenocarcinoma; MUC, mucinous adenocarcinoma; NONE, cases without KRAS or EGFR mutations.